Your browser doesn't support javascript.
loading
Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial.
Augustin, Matthias; Reich, Kristian; Yamauchi, Paul; Pinter, Andreas; Bagel, Jerry; Dahale, Swapnil; You, Ruquan; Bruin, Gerard; Djimopoulos, Jimena; Paguet, Bertrand; Charef, Pascal; Patekar, Manmath; Keefe, Deborah.
Afiliación
  • Augustin M; Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Reich K; Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Yamauchi P; Dermatology Institute & Skin Care Center, Santa Monica, CA, USA.
  • Pinter A; Department of Dermatology, Venereology and Allergology, University of Frankfurt, Frankfurt am Main, Germany.
  • Bagel J; Psoriasis Treatment Center of Central New Jersey, East Windsor, NJ, USA.
  • Dahale S; IQVIA, Mumbai, India.
  • You R; China Novartis Institutes for BioMedical Research, Shanghai, China.
  • Bruin G; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Djimopoulos J; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Paguet B; Novartis Pharma, Basel, Switzerland.
  • Charef P; Novartis Pharma, Basel, Switzerland.
  • Patekar M; Novartis Pharma, Basel, Switzerland.
  • Keefe D; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Br J Dermatol ; 186(6): 942-954, 2022 06.
Article en En | MEDLINE | ID: mdl-34981829
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psoriasis / Productos Biológicos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Br J Dermatol Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psoriasis / Productos Biológicos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Br J Dermatol Año: 2022 Tipo del documento: Article País de afiliación: Alemania